Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphomas,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06382844
What this trial is testing

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Who this might be right for
Cutaneous T-Cell Lymphoma
Instituto de Investigación Biomédica de Salamanca 100
Early research (Phase 1)Ended earlyNCT03103971
What this trial is testing

HuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+14 more
Fred Hutchinson Cancer Center 55
Not applicableUnknownNCT01042717
What this trial is testing

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Who this might be right for
Multiple MyelomaNon-Hodgkins Lymphoma
Shi, Patricia, M.D. 10
Testing effectiveness (Phase 2)Study completedNCT03664635
What this trial is testing

MB-CART20.1 Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more
Miltenyi Biomedicine GmbH 10
Testing effectiveness (Phase 2)UnknownNCT05400876
What this trial is testing

To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma

Who this might be right for
Relapsed/Refractory Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 92
Not applicableStudy completedNCT04605315
What this trial is testing

Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma

Who this might be right for
Pediatric ALLStone, Urinary
Azienda Ospedaliero-Universitaria di Parma 70
Early research (Phase 1)Looking for participantsNCT07570017
What this trial is testing

Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL
Guangzhou Lupeng Pharmaceutical Company LTD. 42
Not applicableUnknownNCT04491825
What this trial is testing

Diagnostic Classifier for Cutaneous T-cell Lymphomas

Who this might be right for
CTCL/ Mycosis Fungoides
Medical University of Vienna 160
Not applicableUnknownNCT06106776
What this trial is testing

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Who this might be right for
Lymphoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Early research (Phase 1)Study completedNCT05149391
What this trial is testing

C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma

Who this might be right for
B Cell Non-Hodgkin's Lymphoma
Peking University 3
Not applicableEnded earlyNCT05410574
What this trial is testing

Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Washington University School of Medicine 17
Large-scale testing (Phase 3)UnknownNCT00091676
What this trial is testing

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Biovest International 629
Early research (Phase 1)Looking for participantsNCT05773040
What this trial is testing

JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

Who this might be right for
LymphomasB-cell Lymphomas
M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)Looking for participantsNCT06006117
What this trial is testing

Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
The Lymphoma Academic Research Organisation 260
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06940791
What this trial is testing

Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

Who this might be right for
Primary Central Nervous System Lymphoma
Kyorin University 92
Testing effectiveness (Phase 2)Looking for participantsNCT06686108
What this trial is testing

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONRelapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Not applicableEnded earlyNCT02704689
What this trial is testing

AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY

Who this might be right for
Degenerative Disc DiseaseSpondylolisthesis, Grade 1Retrolisthesis
VB Spine, LLC 9
Testing effectiveness (Phase 2)Ended earlyNCT04517435
What this trial is testing

ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Deepa Jagadeesh 13
Testing effectiveness (Phase 2)WithdrawnNCT05604417
What this trial is testing

Zandelisib + Tazemetostat in R/R Follicular Lymphoma

Who this might be right for
Relapsed Follicular LymphomaRefractory Follicular Lymphoma
Jacob Soumerai, MD
Next Page